Cargando…
Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer
Introduction: Cancer registries and hospital electronic medical records are commonly used to investigate drug repurposing candidates for cancer. However, administrative data are often more accessible than data from cancer registries and medical records. Therefore, we evaluated if administrative data...
Autores principales: | Tan, George S. Q., Botteri, Edoardo, Wood, Stephen, Sloan, Erica K., Ilomäki, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448902/ https://www.ncbi.nlm.nih.gov/pubmed/37637417 http://dx.doi.org/10.3389/fphar.2023.1227330 |
Ejemplares similares
-
The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
por: Kummer, Marvin, et al.
Publicado: (2020) -
β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis
por: Løfling, L. Lukas, et al.
Publicado: (2022) -
Drug repurposing in cardiovascular inflammation: Successes, failures, and future opportunities
por: Chaffey, Laura, et al.
Publicado: (2022) -
Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities
por: Porta, Exequiel O. J., et al.
Publicado: (2023) -
Repurposing of Bromocriptine for Cancer Therapy
por: Seo, Ean-Jeong, et al.
Publicado: (2018)